Empirical Treatment Approach for Itchy Ear Syndrome: Topical Steroids or Antifungals?
Empirical Treatment for Itchy Ear Syndrome


DOI:
https://doi.org/10.5281/zenodo.16732397Keywords:
Pruritis, Ear Canal, Memetasone Furoate, Ciclopirox/pharmacologyAbstract
Background: “Itchy ear syndrome”, defined as ear itching after exclusion of related pathologies with a thorough physical examination, is common in otolaryngology practice. Despite the fact that it is frequent, high quality evidence regarding its etiology and treatment is lacking. We aimed to investigate whether empirical antifungal therapy is effective in this situation in comparison with corticosteroid therapy and the effectiveness of topical mometasone furoate lotion.
Methods: This retrospective observational study included 57 patients who applied with recurrent ear pruritus, were treated with mometasone or ciclopirox olamine, and who did not have any pathological findings on examination. The patients were retrospectively scanned through the hospital database, called, and asked to fill out a modified form of the 5D itching questionnaire to assess the degree of itching before and after treatment. The results were compared statistically.
Results: Of the 57 patients included, 25 (43.8%) were male and 32 (56.1%) were female. The mean age of the two groups was similar (p=0.915). Twenty-eight (49.1%) patients were treated with ciclopirox olamine, and 29 (50.9%) patients with mometasone. When the scores before and after treatment were compared, the decrease in scores was significant (p<0.001). There was no significant difference between the two cohorts regarding pre-treatment and post-treatment scores (p=0,26 and p=0.22, respectively).
Conclusion: Our findings indicate that topical antifungal treatment with ciclopirox olamine and topical steroid treatment with lotion form mometasone furoate are both effective in the treatment of itchy ear syndrome.
References
Steinhoff M, Cevikbas F, Ikoma A, Berger TG. Pruritus: management algorithms and experimental therapies. Semin Cutan Med Surg. 2011;30(2):127-137. doi:10.1016/j.sder.2011.05.001
Vallur S, Raghavan A, Jagdeeswaran VU, Gampa PK. Evaluation and management of ear itching: our experience. Int J Otorhinolaryngol Head Neck Surg. 2021;7(10):1617 1623.
Babakurban ST, Topal O, Aydin E, Hizal E, Copur S, Ekici MD. Therapeutic effect of Castellani's paint in patients with an itchy ear canal. J Laryngol Otol. 2016;130(10):934-938. doi:10.1017/S0022215116008744
Bilal N, Kirişci Ö, Özkaya E. Demodex Species Infestation in Patients with Ear Itching and Its Relationship to Itch Severity. Turkiye Parazitol Derg. 2017;41(2):87-91. doi:10.5152/tpd.2017.5070
Lee SY, Cho S, Kim M, Lee DH, Kim YH. Comparison of Therapeutic Effects of Topical Calcineurin Inhibitor and Moisturizing Cream on Pruritic External Auditory Canal. J Clin Med. 2021;10(19):4313. Published 2021 Sep 22. doi:10.3390/jcm10194313
Yilmaz B, Canan F, Şengül E, Özkurt FE, Tuna SF, Yildirim H. Type D personality, anxiety, depression and personality traits in patients with isolated itching of the external auditory canal. J Laryngol Otol. 2016;130(1):50-55. doi:10.1017/S0022215115003011
Elman S, Hynan LS, Gabriel V, Mayo MJ. The 5-D itch scale: a new measure of pruritus. Br J Dermatol. 2010;162(3):587-593. doi:10.1111/j.1365-2133.2009.09586.x
Morinaka S. Dermatophytosis of the ear. Otolaryngol Head Neck Surg. 2005;133(1):113-115. doi:10.1016/j.otohns.2005.03.029
Morinaka S. Dermatophytosis of the ear. Otolaryngol Head Neck Surg. 2005;133(1):113-115. doi:10.1016/j.otohns.2005.03.029
Svistushkin VM, Nikiforova GN, Shevchik EA, Zolotova AV. Sovremennye aspekty lecheniya vospalitel'nykh zabolevanii naruzhnogo ukha [Modern aspects of inflammatory external ear diseases treatment]. Vestn Otorinolaringol. 2021;86(3):90-96. doi:10.17116/otorino20218603190
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2025 Başak Yalçıner, Özge Nur Koçak, Gökhan Yalçıner, Onur Büyükkoç, Burak Çelik, Mehmet Ali Babademez

This work is licensed under a Creative Commons Attribution 4.0 International License.